TrialThe Lancet. Oncology2012

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.

Andrea Biondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.